Glycemic control and PTDM In people with diabetes, clinical efficacy of GLP-1RAs for glycemic control has varied in kidney transplant cohorts, with HbA 1c reductions of 0.5% to 2% compared with baseline
Day 1 ADA/AACE Standards of Care Boot Camp Coach Beverly and Diana Isaacs, PharmD, BC-ADM, CDCES co-lead an exciting day that brings the ADA and AACE Standards to life
Draw Your Dose: Insert the syringe tip into the adapter, then flip the bottle and syringe upside down while holding them together
Spatial transcriptomics were conducted on pre-treatment and post-progression samples from two HCC patients
About the author Maia Anderson Maia Anderson is a senior reporter at Healthcare Brew, where she focuses on pharma developments like GLP-1s and psychedelic medicine, pharmacies, and women's health.